Compounded GLP-1 Vial Dates: Beyond-Use, First Puncture and the Cost of Unusable Supply

A large vial can appear inexpensive when its price is divided by many months. But a vial's advertised quantity, unopened beyond-use date and permitted use after puncture are different facts. The price calculation is incomplete until you know how much medication can actually be used within the applicable storage and discard limits, including FDA's recommendation for opened multidose compounded GLP-1 vials.

This guide explains what to ask before paying for a long supply. It does not assign a beyond-use date, determine sterility or authorize use of a vial past its written limits.

Separate the dates on the label

If a label only gives one date, ask the pharmacist what it applies to. A subscription seller's customer-service answer is not necessarily the dispensing pharmacist's instruction for the exact vial you receive. Ask for written clarification before using an unclear product.

FDA's specific recommendation for opened compounded GLP-1 vials

FDA recommends discarding a multidose compounded GLP-1 vial within 28 days after first use, even if medication remains. The agency explicitly says not to continue after 28 days even when the compounder's instructions allow longer, because contamination risk increases². A pharmacy's longer printed use period does not override this recommendation.

This opened-vial limit is different from the pharmacy-assigned unopened beyond-use date. An unopened vial's date does not give permission to keep using it for months after the first puncture. If an applicable beyond-use date, storage problem or pharmacy instruction requires earlier disposal, do not extend use to 28 days. Ask the dispensing pharmacist to explain conflicting instructions and arrange an appropriate supply.

CDC also provides general multidose-vial guidance, with exceptions for a manufacturer's specified opened-vial date¹. That general exception should not be read as permission to disregard FDA's specific recommendation for multidose compounded GLP-1 vials. A single-dose container is different, and branded devices have their own product-specific labeling; this article does not assign every sterile vial the same use period.

Record the first-use date without obscuring the prescription information. Refrigeration does not reset that date or extend the opened-vial limit. Always use a new sterile needle and syringe for each dose, as FDA recommends². Leftover medication and the financial cost of discarding it do not establish safety.

Can a large vial be used for a year?

An advertisement saying “up to a year of medication” may describe the amount of drug divided by a low weekly dose. It does not by itself establish that the same opened vial may be accessed for a year. Ask how many sealed vials are shipped, when each should be opened and whether every planned dose fits the unopened beyond-use date, storage requirements and FDA's 28-day first-use recommendation for each multidose compounded GLP-1 vial. A longer compounder instruction is not a reason to keep using an opened vial beyond 28 days².

For example, a fictional $600 package advertised as six months works out to $100 per month only if six months of usable supply are actually provided. If the written instructions make part of that quantity unusable, the advertised division understates what your usable treatment costs. The answer is a corrected supply and cost explanation, not stretching the use period.

Our monthly cost guide and 12-month comparison help compare billing structures. Add the supply-date question before deciding that a larger prepaid order is the better deal.

What about a warm shipment?

FDA has highlighted concerns about compounded GLP-1 products arriving warm or with inadequate refrigeration and says patients should not use injectable GLP-1 drugs that arrive warm or without adequate refrigeration². If a shipment concerns you, keep the packaging and contact the dispensing pharmacy promptly for product-specific assessment and replacement instructions.

A cold pack's appearance is not a validated temperature history. Do not copy a branded pen's room-temperature allowance onto a compounded vial: a different preparation may have different requirements. Ask what documentation the pharmacy needs and whether you should hold the product pending a response.

The travel and storage guide covers branded-product considerations. It should not be used to invent storage allowances for a compound.

Before paying for multiple months

Request the exact pharmacy name, number of vials, concentration, storage instructions and unopened and after-puncture dates. Ask whether the full supply ships together or in stages. Ask how the plan handles a clinician-directed dose change, an interruption or a replacement for an unsuitable shipment.

Keep medication amounts separate from syringe markings. A label showing milligrams per milliliter is not the same as a dose in syringe units. If a new shipment has a different concentration, ask the pharmacist to explain the written directions rather than reusing the old draw-up amount. For that distinction, read the dose-conversion explanation.

Refund terms affect the budget, not the use instructions

Find out when an order becomes non-refundable and how soon a shipping concern must be reported. Some programs require photographs or a report within a short period. Keep written records of the shipment and correspondence, but do not let a reporting deadline pressure you into using a product you have been told not to use.

If a program cannot explain how its advertised supply fits the pharmacy's dates, request clarification before checkout. A usable-supply comparison is more informative than a low monthly average without a vial schedule. The provider checklist can help organize the rest of that decision.